Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Raltegravir in HIV-infected Patients at Least 60 Years of Age
NCT01335620Phase 4Completed
- Sponsor
- Imperial College London
- Start
- Apr 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Imperial College London. Started Apr 2011; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01335620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01335620.